Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Novartis A G (NVS)’

Merck & Co., Inc. (NYSE:MRK)

The Pharmaceutical Industry’s 10 Biggest R&D Budgets

Innovation is everything when it comes to the pharmaceutical sector. Behind those glorious 75%-plus gross margins associated with branded and patented......(read more)
AstraZeneca plc (ADR) (NYSE:AZN)

Everything You Need to Know About the Upcoming Flu Season

To me, flu season is a lot like Christmas; there’s a defined time period when we expect it to occur, yet it seems to appear earlier and earlier......(read more)
Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Regeneron Pharmaceuticals Inc (REGN): Should You Follow in Sanofi SA (ADR) (SNY)’s Footsteps and Invest in This Booming Biotech?

More than anything, biotech companies need investors who are true believers in their products. In a sector more governed by future prospects than past......(read more)
Abercrombie & Fitch Co. (NYSE:ANF)

SPDR S&P Homebuilders (ETF) (XHB), Abercrombie & Fitch Co. (ANF), Novartis AG (ADR) (NVS): Shorts Are Piling Into These Stocks. Should You Be Worried?

The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Could a Pair of Respiratory Disease Treatments Save This Big Pharma?

GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive......(read more)
Theravance Inc (NASDAQ:THRX)

Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Time to Bet on This Biotech Spinoff?

There hasn’t been a dull moment for investors of Theravance Inc (NASDAQ:THRX) since the company submitted an NDA for COPD/asthma drug BREO before......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Ariad Pharmaceuticals, Inc. (ARIA), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does This Orphan Leukemia Treatment Have Blockbuster Potential?

When most biotech investors think of cancer treatments, they tend to think of large established players like Roche and Amgen. However, more speculative......(read more)
Novartis AG (ADR) (NYSE:NVS)

Novartis AG (ADR) (NVS), Medtronic, Inc. (MDT): Will Smart Pills Revolutionize Health Care?

The ongoing convergence of the tech and health care industries has yielded some remarkable advances in telehealth, electronic health records, or EHRs,......(read more)
Hospira, Inc. (NYSE:HSP)

Hospira, Inc. (HSP), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK): Will This Biotech Approval Start a $100 Billion Trend?

Hospira, Inc. (NYSE:HSP) announced that the European Commission has approved its biosimilar version of Remicade from Johnson & Johnson (NYSE:JNJ......(read more)
Johnson & Johnson (NYSE:JNJ)

Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Will a Band-Aid Be Enough for Johnson & Johnson (JNJ)’s Latest Recall?

Check that bottle of Motrin Infants formula before you give it to a baby. Johnson & Johnson (NYSE:JNJ) recently announced a recall of around 200,000......(read more)
Theravance Inc (NASDAQ:THRX)

GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE): Theravance Inc (THRX) Gets Big Win for New COPD Drug

Trading of biopharmaceutical company Theravance Inc (NASDAQ:THRX) was halted on Tuesday. A major decision hung in the balance as the U.S. Food and Drug......(read more)
The Cooper Companies, Inc.

Johnson & Johnson (JNJ), Novartis AG (ADR) (NVS): The Cooper Companies, Inc. (COO) Leveraging Share Gains for Eye-Opening Growth

The Cooper Companies, Inc. (NYSE:COO), or more formally “The Cooper Companies” is a sort of odd duck in the med-tech world. It’s fairly......(read more)
Incyte Corporation (NASDAQ:INCY)

Incyte Corporation (INCY), Pfizer Inc. (PFE): This Biotech Has So Many Reasons to Be Liked

Earlier this month, I wrote an article explaining that I liked Incyte Corporation (NASDAQ:INCY) on the basis of the blockbuster potential of its only......(read more)
Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ), Forest Laboratories, Inc. (FRX), Pfizer Inc. (PFE): Pharmas Spending the Most to Catch Your Doctor’s Eye

The way to your wallet just might be through your doctor’s eyes. Pharmaceutical firms spend a lot of money to influence physicians to prescribe......(read more)
Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (JNJ), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): The Biggest Winners of the FDA’s Breakthrough Designation

Designed as a way to bring potentially life-changing drugs to pharmacy shelves faster than ever, the Food and Drug Administration Safety and Innovation......(read more)
Novartis AG (ADR) (NYSE:NVS)

Biogen Idec Inc. (BIIB), Incyte Corporation (INCY): Should Novartis AG (ADR) (NVS) Shareholders Be Worried About This?

As an investor in the health care sector, it can sometimes feel like everything — and everyone — is out to get you. The ongoing threat of......(read more)
Eli Lilly & Co. (NYSE:LLY)

Eli Lilly & Co. (LLY), Novartis AG (ADR) (NVS), Shire PLC (ADR) (SHPG): A Closer Look at the Controversial Market Growth of ADHD Treatments

The existence of ADHD, or attention deficit hyperactivity disorder, has been a hot-button topic since the 1970s. On one hand, there are scientists who......(read more)
Incyte Corporation (NASDAQ:INCY)

Incyte Corporation (INCY), Pacific Biosciences of California (PACB), Astex Pharmaceuticals, Inc. (ASTX): 3 Humongous Health-Care Stocks This Week

While the overall market muddled through the past five days, some stocks were on fire. Here are three health-care stocks experiencing humongous gains......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN) and Onyx Pharmaceuticals, Inc. (ONXX): Half a Billion Dollars’ Worth of Drama

A finale has at last arrived for the biotech drama of summer 2013. Amgen, Inc. (NASDAQ:AMGN) announced yesterday that it will buy Onyx Pharmaceuticals......(read more)
Bristol Myers Squibb Co. (NYSE:BMY)

Curis, Inc. (CRIS), Bristol Myers Squibb Co. (BMY), Novartis AG (ADR) (NVS): Can Stopping This Hedgehog Create New Cancer Treatments?

Curis, Inc. (NASDAQ:CRIS) and Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) Genentech unit have stopped a hedgehog — not a spiky little beast, but a......(read more)
GTx, Inc. (NASDAQ:GTXI)

GTx, Inc. (GTXI), Novartis AG (ADR) (NVS): This Week in Biotech

With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into......(read more)
Community Health Systems (NYSE:CYH)

Community Health Systems (CYH), Novartis AG (ADR) (NVS): 7 Things You Need to Know About Obamacare Before 2014

Obamacare. Is. Coming. Well, OK, many parts of the Patient Protection and Affordable Care Act, commonly referred to as Obamacare, have already been implemented......(read more)
Incyte Corporation (NASDAQ:INCY)

Incyte Corporation (INCY), Gilead Sciences, Inc. (GILD): Pop-Worthy Data, Incyte, but Let’s See More

The phase 2 data that Incyte Corporation (NASDAQ:INCY) presented on Wednesday was downright stellar. For a subgroup of the patients, the hazard ratio......(read more)
Incyte Corporation (NASDAQ:INCY)

Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does Incyte Corporation (INCY) Deserve Its New Valuation?

One of the hottest stocks on the market Wednesday was Incyte Corporation (NASDAQ:INCY), a pharmaceutical company specializing in the development of JAK......(read more)
Incyte Corporation (NASDAQ:INCY)

Novartis AG (ADR) (NVS): Why Incyte Corporation (INCY) Shares Skyrocketed

Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case......(read more)
Incyte Corporation (NASDAQ:INCY)

Novartis AG (ADR) (NVS), Amgen, Inc. (AMGN): Incyte Corporation (INCY) Jumps on Jakafi Results

Incyte Corporation (NASDAQ:INCY) today announced positive results from a phase 2 study of its drug Jakafi in treating refractory metastatic pancreatic......(read more)
Biogen Idec Inc (NASDAQ:BIIB)

Biogen Idec Inc. (BIIB), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Novartis AG (ADR) (NVS): Companies Leading the Fight Against Multiple Sclerosis

It’s a disease that doesn’t often find itself in the spotlight, but multiple sclerosis is quickly becoming an ailment that drugmakers are......(read more)
Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (MRK), Novartis AG (ADR) (NVS): One Hidden Pharmaceutical Technology for Your Portfolio

Pharmaceutical companies are always looking for competitive advantages. Historically, getting a leg up on the competition has centered on identifying......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Novartis AG (ADR) (NVS): This Company’s Debt Might Be a Concern

GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of making illegal payments to Chinese doctors and government officials by siphoning them through......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Ariad Pharmaceuticals, Inc. (ARIA), Bristol-Myers Squibb Co (BMY): The Most Important Number for This Drug Launch

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) gave investors a closer look at how the launch of its leukemia drug Iclusig is going when it released second......(read more)
Roche Holding Ltd

Roche Holding Ltd. (ADR) (RHHBY), Novartis AG (ADR) (NVS): Should You Keep an Eye on These Eye Treatment Biotechs?

Investors might want to keep their eyes on the eye care industry, as the battle for eye treatments heats up across the biotech sector. Two eye diseases......(read more)
Theravance Inc (NASDAQ:THRX)

Theravance Inc (THRX), Novartis AG (ADR) (NVS): Respiratory Drug Maker About to Take Off

Chronic obstructive pulmonary disease (COPD) is America’s third leading cause of death. It is a lung disease caused due to continuous poor airflow as......(read more)
Eli Lilly & Co. (NYSE:LLY)

Eli Lilly & Co. (LLY), Novartis AG (ADR) (NVS): Is This Company Getting Ahead of Itself?

The biotechnology industry is one of the riskiest places to put your money. However, when companies get everything right, the fortunes made there are......(read more)
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

Celgene Corporation (CELG), Novartis AG (ADR) (NVS): Momenta Pharmaceuticals, Inc. (MNTA) Earnings Remind Investors of Growing Pains

The investing waters can get pretty choppy from time to time with a developmental stage company. A look at the five-year chart of Momenta Pharmaceuticals......(read more)
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)

3 Things You Need to Know From Astex Pharmaceuticals, Inc. (ASTX)’s Q2 Earnings

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) announced its second-quarter financial results on Thursday prior to the market open. The company reported a......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN), Baxter International Inc. (BAX): Can the FDA Make Up Its Mind Already?

It isn’t very often that an agency sometimes accused of over-regulating an industry can be ridiculed for not regulating enough, but that’s......(read more)
Incyte Corporation (NASDAQ:INCY)

Incyte Corporation (INCY) Earnings Cruise on Jakafi Growth

Budding biotech company Incyte Corporation (NASDAQ:INCY), which specializes in developing novel JAK inhibitors, released solid second-quarter earnings......(read more)
Biogen Idec Inc (NASDAQ:BIIB)

Biogen Idec Inc (BIIB), Pfizer Inc. (PFE): Out With the Old, In With the New in Treating MS

Hidden beneath all the numbers and metrics in Biogen Idec Inc (NASDAQ:BIIB)‘s recent earnings report is a key confirmation of a shifting market......(read more)
Theravance Inc (NASDAQ:THRX)

Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Which of These COPD Treatments Will Come Out on Top?

To most people, cigarettes are often associated with lung cancer. However, smoking also causes other severe respiratory problems, such as COPD (chronic......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN): Extremely Expensive Drugs for Extremely Rare Diseases

The biotech industry is known for fast paced acquisitions and rapid market consolidation. Larger pharmaceutical companies headed towards patent cliffs......(read more)
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

Momenta Pharmaceuticals, Inc. (MNTA) Latest to Take Advantage of Teva Pharmaceutical Industries Ltd (ADR) (TEVA)’s Patent Woes

The United States Court of Appeals is making this one miserable summer for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). In June, it was determined......(read more)
Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE): As Healthcare Demand Rises, So Will This Company’s Profits

The aging population as well as the higher number of people who will receive benefits under new healthcare laws should combine to produce rising profits......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Will This Biotech Bidding War Lead You to Larger Gains?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) added 3% to its one-month 60% gains on Monday because of continued speculation of a buyout. Reportedly, four......(read more)
Alkermes Plc (NASDAQ:ALKS)

Alkermes Plc (ALKS), Quest Diagnostics Inc (DGX): This Week in Biotech

With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
Novartis AG (ADR) (NYSE:NVS)

A Look at Novartis AG (ADR) (NVS)’ Second Quarter

The story of the second quarter for Novartis AG (ADR) (NYSE:NVS) offered mixed results for investors. The company’s net sales were up 1%, and EPS......(read more)
Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Which Pharmaceutical Giant Is the Best Investment?

Amid sluggish sales growth, the Pharmaceutical Industry giants are struggling with declining revenues and profits. Banking on the introduction of new......(read more)
Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (MRK): This Pharmaceutical Company Is Poised for Wellness

Sustainability and a strong pipeline are the two tests that best evaluate a pharmaceutical company. Merck & Co., Inc. (NYSE:MRK) scores high on both......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Pfizer Inc. (PFE): 3 Potential Game Changers for COPD

Over 13 million Americans have it. More than 120,000 of them die every year. Chronic obstructive pulmonary disease, or COPD, stands as the third leading......(read more)
Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ), Novartis AG (ADR) (NVS): Don’t Let Your Attention Defect

Ineffective drugs being sold for billions in global sales. According to an article in the Wall Street Journal, a study in Quebec on 4,000 students (gathering......(read more)
The Boeing Company (NYSE:BA)

The Boeing Company (BA), Lockheed Martin Corporation (LMT) – Pentagon Watch: Where Did Your Tax Dollars Go This Week?

The U.S. military has a reputation as a somewhat secretive organization. But in one respect at least, the Pentagon ranks among our most transparent government......(read more)